Cargando…

Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study

OBJECTIVES: To investigate treatment adherence in patients with type 2 diabetes and to evaluate its associated factors. METHODS: The Summary of Diabetes Self-Care Activities (SDSCA) questionnaire was used to assess treatment adherence. Good adherence was defined as ≥5 days a week in each SDSCA item....

Descripción completa

Detalles Bibliográficos
Autores principales: Marinho, Fernanda S., Moram, Camila B. M., Rodrigues, Priscila C., Leite, Nathalie C., Salles, Gil F., Cardoso, Claudia R. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288575/
https://www.ncbi.nlm.nih.gov/pubmed/30599003
http://dx.doi.org/10.1155/2018/8970196
_version_ 1783379823282880512
author Marinho, Fernanda S.
Moram, Camila B. M.
Rodrigues, Priscila C.
Leite, Nathalie C.
Salles, Gil F.
Cardoso, Claudia R. L.
author_facet Marinho, Fernanda S.
Moram, Camila B. M.
Rodrigues, Priscila C.
Leite, Nathalie C.
Salles, Gil F.
Cardoso, Claudia R. L.
author_sort Marinho, Fernanda S.
collection PubMed
description OBJECTIVES: To investigate treatment adherence in patients with type 2 diabetes and to evaluate its associated factors. METHODS: The Summary of Diabetes Self-Care Activities (SDSCA) questionnaire was used to assess treatment adherence. Good adherence was defined as ≥5 days a week in each SDSCA item. Pain, emotional, and physical domains of the SF-36 quality of life questionnaire and the Canadian Occupational Performance Measure (COPM) were also evaluated. Multivariable logistic regressions explored the independent correlates of good general adherence and of specific items of the SDSCA (diet, exercise, and medications). RESULTS: Good adherence was 93.5% for medication use, 59.3% for foot care, 56.1% for blood glucose monitoring, 29.2% for diet, and 22.5% for exercise. Patients with general good adherence had lower BMI, better serum lipid profile, higher values of functional capacity, emotional and pain domains of SF-36, better occupational performance, and lower prevalence of pain or limitation in the upper and lower limbs than patients with worse adherence. The variables associated with good adherence were younger age, lower BMI, presence of macrovascular complications, better occupational performance and emotional domain of SF-36, and higher HDL cholesterol levels. The presence of pain/limitation in the upper limbs was associated with worse adherence. Good medication adherence was associated with longer diabetes duration, lower BMI, and lower HbA(1c) levels. Higher values of pain and emotional domains of the SF-36 and lower BMI were related to better exercise and diet adherence, while the presence of peripheral neuropathy and joint pain/limitation were associated with worse exercise adherence. CONCLUSIONS: Emotional and physical performances are important determinants of good diabetic treatment adherence. Good adherence has beneficial impact on BMI, lipid, and glycemic control.
format Online
Article
Text
id pubmed-6288575
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-62885752018-12-31 Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study Marinho, Fernanda S. Moram, Camila B. M. Rodrigues, Priscila C. Leite, Nathalie C. Salles, Gil F. Cardoso, Claudia R. L. J Diabetes Res Research Article OBJECTIVES: To investigate treatment adherence in patients with type 2 diabetes and to evaluate its associated factors. METHODS: The Summary of Diabetes Self-Care Activities (SDSCA) questionnaire was used to assess treatment adherence. Good adherence was defined as ≥5 days a week in each SDSCA item. Pain, emotional, and physical domains of the SF-36 quality of life questionnaire and the Canadian Occupational Performance Measure (COPM) were also evaluated. Multivariable logistic regressions explored the independent correlates of good general adherence and of specific items of the SDSCA (diet, exercise, and medications). RESULTS: Good adherence was 93.5% for medication use, 59.3% for foot care, 56.1% for blood glucose monitoring, 29.2% for diet, and 22.5% for exercise. Patients with general good adherence had lower BMI, better serum lipid profile, higher values of functional capacity, emotional and pain domains of SF-36, better occupational performance, and lower prevalence of pain or limitation in the upper and lower limbs than patients with worse adherence. The variables associated with good adherence were younger age, lower BMI, presence of macrovascular complications, better occupational performance and emotional domain of SF-36, and higher HDL cholesterol levels. The presence of pain/limitation in the upper limbs was associated with worse adherence. Good medication adherence was associated with longer diabetes duration, lower BMI, and lower HbA(1c) levels. Higher values of pain and emotional domains of the SF-36 and lower BMI were related to better exercise and diet adherence, while the presence of peripheral neuropathy and joint pain/limitation were associated with worse exercise adherence. CONCLUSIONS: Emotional and physical performances are important determinants of good diabetic treatment adherence. Good adherence has beneficial impact on BMI, lipid, and glycemic control. Hindawi 2018-11-27 /pmc/articles/PMC6288575/ /pubmed/30599003 http://dx.doi.org/10.1155/2018/8970196 Text en Copyright © 2018 Fernanda S. Marinho et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Marinho, Fernanda S.
Moram, Camila B. M.
Rodrigues, Priscila C.
Leite, Nathalie C.
Salles, Gil F.
Cardoso, Claudia R. L.
Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study
title Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study
title_full Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study
title_fullStr Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study
title_full_unstemmed Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study
title_short Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study
title_sort treatment adherence and its associated factors in patients with type 2 diabetes: results from the rio de janeiro type 2 diabetes cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288575/
https://www.ncbi.nlm.nih.gov/pubmed/30599003
http://dx.doi.org/10.1155/2018/8970196
work_keys_str_mv AT marinhofernandas treatmentadherenceanditsassociatedfactorsinpatientswithtype2diabetesresultsfromtheriodejaneirotype2diabetescohortstudy
AT moramcamilabm treatmentadherenceanditsassociatedfactorsinpatientswithtype2diabetesresultsfromtheriodejaneirotype2diabetescohortstudy
AT rodriguespriscilac treatmentadherenceanditsassociatedfactorsinpatientswithtype2diabetesresultsfromtheriodejaneirotype2diabetescohortstudy
AT leitenathaliec treatmentadherenceanditsassociatedfactorsinpatientswithtype2diabetesresultsfromtheriodejaneirotype2diabetescohortstudy
AT sallesgilf treatmentadherenceanditsassociatedfactorsinpatientswithtype2diabetesresultsfromtheriodejaneirotype2diabetescohortstudy
AT cardosoclaudiarl treatmentadherenceanditsassociatedfactorsinpatientswithtype2diabetesresultsfromtheriodejaneirotype2diabetescohortstudy